Total Payments
$4,022
2023 Payments
$87.25
Companies
40
Transactions
216
Medicare Patients
6,828
Medicare Billing
$2.6M
Payment Breakdown by Category
Food & Beverage$3,654 (90.9%)
Education$367.58 (9.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,654 | 202 | 90.9% |
| Education | $367.58 | 14 | 9.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $506.67 | 34 | $0 (2021) |
| Amgen Inc. | $482.32 | 15 | $0 (2022) |
| Janssen Biotech, Inc. | $386.61 | 42 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $289.87 | 16 | $0 (2023) |
| PFIZER INC. | $245.61 | 14 | $0 (2021) |
| Pharmacyclics LLC, an AbbVie Company | $184.91 | 6 | $0 (2022) |
| Lilly USA, LLC | $179.49 | 9 | $0 (2021) |
| GENZYME CORPORATION | $173.43 | 8 | $0 (2021) |
| Celgene Corporation | $138.99 | 6 | $0 (2020) |
| Merck Sharp & Dohme LLC | $127.55 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $87.25 | 4 | Merck Sharp & Dohme LLC ($39.62) |
| 2022 | $303.94 | 18 | Janssen Biotech, Inc. ($125.96) |
| 2021 | $642.10 | 28 | E.R. Squibb & Sons, L.L.C. ($159.65) |
| 2020 | $420.21 | 21 | Seagen Inc. ($73.17) |
| 2019 | $1,103 | 69 | E.R. Squibb & Sons, L.L.C. ($172.59) |
| 2018 | $802.35 | 43 | Pharmacyclics LLC, An AbbVie Company ($116.27) |
| 2017 | $663.44 | 33 | Amgen Inc. ($124.10) |
All Payment Transactions
216 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/18/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug), TASIGNA | Food and Beverage | In-kind items and services | $34.39 | General |
| Category: Oncology | ||||||
| 05/07/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Education | In-kind items and services | $19.81 | General |
| Category: ONCOLOGY | ||||||
| 04/08/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Education | In-kind items and services | $19.81 | General |
| Category: ONCOLOGY | ||||||
| 03/29/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Oncology | ||||||
| 12/16/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Oncology | ||||||
| 12/14/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Oncology | ||||||
| 12/09/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Oncology | ||||||
| 11/17/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Oncology | ||||||
| 11/03/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/05/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: Oncology | ||||||
| 09/08/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Oncology | ||||||
| 09/07/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $38.70 | General |
| Category: Oncology | ||||||
| 08/17/2022 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Oncology | ||||||
| 07/13/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $27.70 | General |
| 07/07/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: Oncology | ||||||
| 06/28/2022 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: Hematology | ||||||
| 05/18/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 05/12/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Oncology | ||||||
| 05/11/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: Oncology | ||||||
| 02/15/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $2.94 | General |
| Category: Oncology | ||||||
| 12/20/2021 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $25.52 | General |
| Category: ONCOLOGY | ||||||
| 12/15/2021 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: Oncology | ||||||
| 12/13/2021 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 31 | 1,556 | 16,412 | $1.1M | $248,852 |
| 2021 | 49 | 2,572 | 53,753 | $3.1M | $1.1M |
| 2020 | 49 | 2,700 | 90,760 | $3.4M | $1.2M |
Total Patients
6,828
Total Services
160,925
Medicare Billing
$2.6M
Procedure Codes
129
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 176 | 337 | $132,104 | $52,634 | 39.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 20 | 2,580 | $132,135 | $44,069 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 399 | $117,306 | $43,562 | 37.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 50 | 193 | $95,728 | $27,311 | 28.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 17 | 112 | $227,948 | $15,832 | 6.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 22 | 143 | $33,605 | $9,719 | 28.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 45 | 81 | $27,135 | $6,923 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 81 | $16,362 | $6,191 | 37.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 36 | 197 | $21,473 | $6,036 | 28.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 81 | $17,334 | $4,972 | 28.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 148 | 406 | $22,736 | $4,249 | 18.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 173 | 519 | $21,798 | $3,990 | 18.3% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 36 | 195 | $14,820 | $3,157 | 21.3% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2022 | 14 | 45 | $10,890 | $3,085 | 28.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 44 | 172 | $12,384 | $2,248 | 18.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 14 | 76 | $8,132 | $2,244 | 27.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $7,345 | $2,007 | 27.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 21 | 61 | $8,296 | $1,930 | 23.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 28 | 48 | $6,720 | $1,619 | 24.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 172 | 491 | $9,329 | $1,460 | 15.7% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2022 | 14 | 54 | $4,644 | $1,450 | 31.2% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2022 | 14 | 7,350 | $42,263 | $1,070 | 2.5% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 34 | 68 | $4,216 | $908.82 | 21.6% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2022 | 19 | 650 | $62,075 | $500.57 | 0.8% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2022 | 31 | 69 | $1,794 | $413.94 | 23.1% |
About Dr. Matthew Sirott, M.D
Dr. Matthew Sirott, M.D is a Hematology & Oncology healthcare provider based in Pleasant Hill, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023014461.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Sirott, M.D has received a total of $4,022 in payments from pharmaceutical and medical device companies, with $87.25 received in 2023. These payments were reported across 216 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($3,654).
As a Medicare-enrolled provider, Sirott has provided services to 6,828 Medicare beneficiaries, totaling 160,925 services with total Medicare billing of $2.6M. Data is available for 3 years (2020–2022), covering 129 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Pleasant Hill, CA
- Active Since 06/21/2005
- Last Updated 08/03/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1023014461
Products in Payments
- OPDIVO (Biological) $365.70
- Imbruvica (Drug) $154.98
- IMBRUVICA (Drug) $147.51
- IMLYGIC (Biological) $124.10
- KEYTRUDA (Biological) $111.37
- PADCEV (Biological) $91.16
- Nplate (Biological) $87.29
- JEVTANA (Drug) $86.05
- CYRAMZA (Drug) $84.78
- ERLEADA (Drug) $83.35
- Erleada (Drug) $80.42
- Revlimid (Drug) $75.92
- DARZALEX (Biological) $71.45
- ZOLADEX (Drug) $69.70
- INLYTA (Drug) $65.54
- EVENITY (Biological) $60.17
- NINLARO (Drug) $55.21
- LUMAKRAS (Drug) $54.42
- BOSULIF (Drug) $52.51
- ALIMTA (Drug) $50.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Pleasant Hill
Dr. Gigi Chen, M.d, M.D
Hematology & Oncology — Payments: $132,511
Hematology & Oncology $132,511
Dr. Shoba Kankipati, M.d, M.D
Hematology & Oncology — Payments: $71,127
Hematology & Oncology $71,127
Dr. Leann Blankenship, M.d, M.D
Hematology & Oncology — Payments: $18,600
Hematology & Oncology $18,600
Donna Saba, Fnp, FNP
Hematology & Oncology — Payments: $16,904
Hematology & Oncology $16,904
Yelena Krupitskaya, M.d, M.D
Hematology & Oncology — Payments: $9,191
Hematology & Oncology $9,191
Robert Robles, M.d, M.D
Hematology & Oncology — Payments: $8,627
Hematology & Oncology $8,627